UTMD
Utah Medical Products Inc
NASDAQ: UTMD · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$66.80
-2.96% today
Updated 2026-10-29
Market cap
$231.97M
P/E ratio
21.87
P/S ratio
6.64x
EPS (TTM)
$3.34
Dividend yield
0.42%
52W range
$53 – $77
Volume
0.0M
Utah Medical Products Inc (UTMD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$66.80
12-Month target
$63.76
2030 Target
—
Intrinsic (DCF)
$42.70
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 21.87x (capped 25x) · Margin: 30.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.